english.prescrire.org

Welcome to the Prescrire in English website

Reliable, rigorously independent information on treatments and healthcare strategies,
to enable fully informed decision-making. Prescrire is financed by its subscribers.
No grants, no advertising. No shareholders, no sponsors.

In Prescrire's Spotlight

The annual Prescrire Awards are given out in Paris: 3 winning drugs, but no "Pilule d'Or"

25 January 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
The Prescrire Awards for 2017: one winner for Drug Packaging

25 January 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Prescrire's Information Awards for 2017: 8 drug companies (out of 101 contacted) are honoured for the quality of information provided

25 January 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Independent French journal Prescrire updates its list of drugs to avoid, in the name of better patient care

25 January 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Injectable methotrexate and ectopic pregnancy. An alternative to surgery, but patients must be made aware of the risks

1 February 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
In the February issue of Prescrire International: Localised prostate cancer - immediate treatment, or not?

1 February 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Levothyroxine: problems caused by a change in formulation were foreseeable

1 February 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Tremors: sometimes drug-induced

1 February 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Prescrire's policy advocacy: advancing healthcare policy

1 December 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
"Top Texts of 2017", from the Editors of Prescrire International

1 December 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Receive the free, monthly "Independent Drug & Healthcare Newsletter"

1 September 2017

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Subscribe online for full access to content from Prescrire International

1 September 2017